1,2-dimethylhydrazine decreases expression ISO Mapre1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAPRE1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Mapre1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAPRE1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO Mapre1 (Mus musculus) 6480464 Estradiol results in increased expression of MAPRE1 mRNA CTD PMID:14664709 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Mapre1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAPRE1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO MAPRE1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of MAPRE1 mRNA CTD PMID:22574217 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2-hydroxypropanoic acid increases expression ISO MAPRE1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of MAPRE1 mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of MAPRE1 mRNA CTD PMID:21061450 4,4'-diaminodiphenylmethane decreases expression ISO Mapre1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of MAPRE1 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO Mapre1 (Mus musculus) 6480464 Fenretinide results in increased expression of MAPRE1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO Mapre1 (Mus musculus) 6480464 Fenretinide results in decreased expression of MAPRE1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAPRE1 mRNA CTD PMID:24780913 and PMID:30047161 aflatoxin B1 increases expression ISO MAPRE1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MAPRE1 mRNA CTD PMID:27153756 amitrole increases expression EXP 6480464 Amitrole results in increased expression of MAPRE1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPRE1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO MAPRE1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAPRE1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Mapre1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MAPRE1 mRNA CTD PMID:23650126 arsenous acid increases expression ISO MAPRE1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAPRE1 mRNA CTD PMID:20458559 benzatropine decreases expression ISO MAPRE1 (Homo sapiens) 6480464 Benztropine results in decreased expression of MAPRE1 protein CTD PMID:34122009 benzo[a]pyrene decreases methylation ISO MAPRE1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of MAPRE1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO MAPRE1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAPRE1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO MAPRE1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAPRE1 promoter CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAPRE1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO MAPRE1 (Homo sapiens) 6480464 bisphenol A results in increased expression of MAPRE1 protein CTD PMID:34186270 bisphenol A decreases methylation ISO MAPRE1 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of MAPRE1 gene CTD PMID:31601247 bisphenol A decreases expression ISO Mapre1 (Mus musculus) 6480464 bisphenol A results in decreased expression of MAPRE1 mRNA and bisphenol A results in decreased expression of MAPRE1 protein CTD PMID:33221593 and PMID:35999755 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAPRE1 mRNA CTD PMID:30816183 and PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAPRE1 gene CTD PMID:28505145 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of MAPRE1 mRNA CTD PMID:24136188 cadmium atom multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAPRE1 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAPRE1 protein CTD PMID:33040242 and PMID:35301059 cadmium dichloride increases expression ISO Mapre1 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MAPRE1 mRNA CTD PMID:20883709 cadmium dichloride multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAPRE1 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAPRE1 protein CTD PMID:33040242 and PMID:35301059 caffeine decreases phosphorylation ISO MAPRE1 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of MAPRE1 protein CTD PMID:35688186 carbon nanotube affects expression ISO Mapre1 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of MAPRE1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Mapre1 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of MAPRE1 mRNA CTD PMID:25554681 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of MAPRE1 mRNA CTD PMID:17602206 clozapine decreases expression ISO MAPRE1 (Homo sapiens) 6480464 Clozapine results in decreased expression of MAPRE1 protein CTD PMID:34122009 clozapine multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of MAPRE1 protein CTD PMID:34122009 copper(II) sulfate increases expression ISO MAPRE1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MAPRE1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO MAPRE1 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of MAPRE1 protein CTD PMID:35688186 Cuprizon multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of MAPRE1 protein and [Cuprizone co-treated with Haloperidol] results in decreased expression of MAPRE1 protein CTD PMID:34122009 dextran sulfate decreases expression ISO Mapre1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of MAPRE1 protein CTD PMID:35999755 diarsenic trioxide increases expression ISO MAPRE1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAPRE1 mRNA CTD PMID:20458559 diethylstilbestrol increases expression ISO Mapre1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of MAPRE1 mRNA CTD PMID:14664709 doxorubicin decreases expression ISO MAPRE1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MAPRE1 mRNA CTD PMID:29803840 ethanol affects splicing ISO Mapre1 (Mus musculus) 6480464 Ethanol affects the splicing of MAPRE1 mRNA CTD PMID:30319688 fenthion increases expression ISO Mapre1 (Mus musculus) 6480464 Fenthion results in increased expression of MAPRE1 mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of MAPRE1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Mapre1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAPRE1 mRNA CTD PMID:22206623 folic acid decreases expression ISO Mapre1 (Mus musculus) 6480464 Folic Acid results in decreased expression of MAPRE1 mRNA CTD PMID:25629700 FR900359 decreases phosphorylation ISO MAPRE1 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of MAPRE1 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAPRE1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of MAPRE1 mRNA CTD PMID:24136188 haloperidol multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Cuprizone co-treated with Haloperidol] results in decreased expression of MAPRE1 protein CTD PMID:34122009 ivermectin decreases expression ISO MAPRE1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAPRE1 protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MAPRE1 mRNA CTD PMID:35877022 methimazole increases expression EXP 6480464 Methimazole results in increased expression of MAPRE1 mRNA CTD PMID:30047161 mitomycin C increases expression ISO MAPRE1 (Homo sapiens) 6480464 Mitomycin results in increased expression of MAPRE1 mRNA CTD PMID:12760830 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAPRE1 gene CTD PMID:33148267 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of MAPRE1 mRNA CTD PMID:19638242 nickel atom increases expression ISO MAPRE1 (Homo sapiens) 6480464 Nickel results in increased expression of MAPRE1 mRNA CTD PMID:24768652 and PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAPRE1 mRNA CTD PMID:22546817 Nivalenol increases expression ISO Mapre1 (Mus musculus) 6480464 nivalenol results in increased expression of MAPRE1 mRNA CTD PMID:35016910 ochratoxin A decreases expression ISO MAPRE1 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of MAPRE1 mRNA CTD PMID:19287073 and PMID:29098329 ochratoxin A decreases acetylation ISO MAPRE1 (Homo sapiens) 6480464 ochratoxin A results in decreased acetylation of MAPRE1 promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [ochratoxin A results in decreased acetylation of MAPRE1 promoter] which results in decreased expression of MAPRE1 mRNA CTD PMID:29098329 ozone multiple interactions ISO Mapre1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MAPRE1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAPRE1 mRNA CTD PMID:34911549 paclitaxel multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 olesoxime inhibits the reaction [Paclitaxel results in decreased localization of MAPRE1 protein] CTD PMID:20417191 paclitaxel decreases localization ISO MAPRE1 (Homo sapiens) 6480464 Paclitaxel results in decreased localization of MAPRE1 protein CTD PMID:20417191 paracetamol affects expression ISO Mapre1 (Mus musculus) 6480464 Acetaminophen affects the expression of MAPRE1 mRNA CTD PMID:17562736 paracetamol increases expression ISO MAPRE1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAPRE1 mRNA CTD PMID:21420995 pentachlorophenol increases expression ISO Mapre1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of MAPRE1 mRNA CTD PMID:23892564 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAPRE1 gene CTD PMID:33148267 phenobarbital affects expression ISO MAPRE1 (Homo sapiens) 6480464 Phenobarbital affects the expression of MAPRE1 mRNA CTD PMID:19159669 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MAPRE1 mRNA CTD PMID:19162173 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of MAPRE1 mRNA CTD PMID:26923065 rac-lactic acid increases expression ISO MAPRE1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of MAPRE1 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of MAPRE1 mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAPRE1 protein CTD PMID:35544339 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of MAPRE1 mRNA CTD PMID:22431001 sodium arsenate increases expression ISO Mapre1 (Mus musculus) 6480464 sodium arsenate results in increased expression of MAPRE1 mRNA CTD PMID:21795629 and PMID:30953684 sodium arsenate decreases expression ISO Mapre1 (Mus musculus) 6480464 sodium arsenate results in decreased expression of MAPRE1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO MAPRE1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAPRE1 mRNA CTD PMID:12760830 sodium arsenite increases expression ISO Mapre1 (Mus musculus) 6480464 sodium arsenite results in increased expression of MAPRE1 mRNA CTD PMID:20883709 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of MAPRE1 mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of MAPRE1 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of MAPRE1 mRNA CTD PMID:30047161 tetrachloromethane multiple interactions EXP 6480464 [Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of MAPRE1 protein CTD PMID:25303780 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAPRE1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAPRE1 mRNA CTD PMID:23411599 and PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MAPRE1 mRNA CTD PMID:33387578 valproic acid decreases expression ISO Mapre1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of MAPRE1 mRNA CTD PMID:21427059 valproic acid affects expression ISO MAPRE1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAPRE1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAPRE1 mRNA CTD PMID:19015723 vincristine decreases localization ISO MAPRE1 (Homo sapiens) 6480464 Vincristine results in decreased localization of MAPRE1 protein CTD PMID:20417191 vincristine multiple interactions ISO MAPRE1 (Homo sapiens) 6480464 olesoxime inhibits the reaction [Vincristine results in decreased localization of MAPRE1 protein] CTD PMID:20417191 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of MAPRE1 mRNA CTD PMID:19111725 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of MAPRE1 mRNA CTD PMID:19111725
